Company
US Antibiotics
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
12
5 still marketed
Novel approvals
1
Approvals since 2021
0
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Augmentin Xr new use Jun 15, 2005
- Augmentin Es-600 new use Dec 17, 2004
- Augmentin Xr approved Sep 25, 2002
- Augmentin Es-600 approved Jun 22, 2001
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (5)
Newest FDA action first.
- Augmentin '125' Amoxicillin, Clavulanate Potassium · 1984
- Augmentin Es-600 Amoxicillin, Clavulanate Potassium · 2001
- Augmentin '875' Amoxicillin, Clavulanate Potassium · 1996
- Augmentin Xr Amoxicillin, Clavulanate Potassium · 2002
- Amoxil Amoxicillin · 1999
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.